Characteristic | MG group, n = 17, 40.48% | CT + MG group, n = 25, 59.52% | P-value |
---|---|---|---|
Age, yearsc | 50.00 ± 7.82 | 57.20 ± 8.29 | 0.007b |
Size of microcalcification area, CC view, mmc | 8.97 ± 5.79 | 16.16 ± 9.67 | 0.010a |
Size of microcalcification area, MLO view, mmc | 10.61 ± 6.16 | 15.96 ± 8.98 | 0.039a |
Max diameter of calcified nodule, CC view, mmc | 0.70 ± 0.43 | 1.54 ± 1.01 | 0.001b |
Max diameter of calcified nodule, MLO view, mmc | 0.74 ± 0.40 | 1.53 ± 0.95 | 0.001b |
Average gray value of calcified area, MLOc | 2,565.16 ± 254.58 | 2,553.16 ± 168.85 | 0.855 |
Average gray value of paraglandular, MLOc | 2,494.09 ± 254.42 | 2458.13 ± 175.80 | 0.590 |
Gray ratio, calcified area /paraglandular, MLOc | 1.03 ± 0.22 | 1.04 ± 0.21 | 0.140 |
Gray difference, calcified area - paraglandular, MLOc | 71.06 ± 54.22 | 95.03 ± 49.50 | 0.146 |
Tumor size, cmc | 1.23 ± 1.13 | 2.01 ± 1.20 | 0.073 |
Estrogen receptor, % | 71.54 ± 32.11 | 57.59 ± 39.50 | 0.264 |
Progesterone receptor, % | 54.62 ± 31.52 | 36.90 ± 32.19 | 0.126 |
HER-2 (%) | |||
Negative | 16 (94.12%) | 19 (76.00%) | 0.122 |
Positive | 1 (5.88%) | 6 (24.00%) | |
Ki67 (%) | 31.54 ± 24.44 | 29.15 ± 16.21 | 0.759 |
Surgical type | |||
Breast-conserving | 4 (23.53%) | 2 (8.00%) | 0.158 |
Mastectomy, ± reconstruction | 13 (76.47%) | 23 (92.00%) | |
SLNB (%) | |||
Negative | 13 (76.47%) | 19 (76.00%) | 0.972 |
Positive | 4 (23.53%) | 6 (24.00%) |